Results 101 to 110 of about 542,634 (177)

Transforming Growth Factor-β Drives Epithelial Mesenchymal Transition and Reduces Synthesis of Unelaborated O-GalNAc Glycans in Breast Cancer Cells. [PDF]

J Histochem Cytochem
Cull J, Pink RC, Samuel P, Brooks SA.
europepmc   +1 more source

Editorial: New Insights on Sialic Acid and Sialylated Glycans in the Tumorigenic Process. [PDF]

Front Oncol
Willand-Charnley RA.
europepmc   +1 more source

The glycobiology of prostate cancer: an update. [PDF]

Oncogene
Hodgson K, Orozco-Moreno M, Peng Z, Blencoe L, Sharp MJ, Smith E, Grimsley G, Elliott DJ, Beatson R, Drake RR, Munkley J.   +10 more
europepmc   +1 more source

Sialic acid <i>cis</i>-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity. [PDF]

Oncoimmunology
van Eck van der Sluijs J, Valk AHC, van Houtum EJH, Kers-Rebel ED, Looman M, Hobo W, Marneth AE, Dolstra H, van den Boogaard L, Büll C, Cornelissen LAM, Adema GJ.   +11 more
europepmc   +1 more source

O-glycosylation in Cancer: Emerging Paradigms and Prospects for Precision Oncology. [PDF]

Int J Biol Sci
Wei J, Hu S, Chen W, Paek HS, Liu G, Pan Y.   +5 more
europepmc   +1 more source

Structural Basis for how Sialoglycan-binding Viridans Streptococci Accommodate Ligands that Exceed the Characterized Binding Site. [PDF]

MicroPubl Biol
Morrison KM, Martin K, Yu H, Chen X, Iverson TM.   +4 more
europepmc   +1 more source

Glycomic Insights in Gynecological Disease: From Molecular Mechanisms to Precision Diagnostics and Therapeutics. [PDF]

Int J Mol Sci
Pásztor R, Váradi C.
europepmc   +1 more source

Sialic acids in cancer biology and immunity-recent advancements. [PDF]

J Biol Chem
van Vliet SJ, van Kooyk Y.
europepmc   +1 more source

Unraveling the glyco-immunity nexus in pancreatic cancer. [PDF]

Mol Cancer
Rajesh C, Cummings RD, Radhakrishnan P.
europepmc   +1 more source